PublisherDOIYearVolumeIssuePageTitleAuthor(s)Link
Respirology10.1111/resp.13420_456201823254-254DIRECT AND INDIRECT COSTS OF CHRONIC OBSTRUCTIVE PULMONARY DISEASE IN KOREAhttps://api.wiley.com/onlinelibrary/tdm/v1/articles/10.1111%2Fresp.13420_456, http://onlinelibrary.wiley.com/wol1/doi/10.1111/resp.13420_456/fullpdf
International Journal of Chronic Obstructive Pulmonary Disease10.2147/copd.s1328252017Volume 121395-1400The direct and indirect costs of managing chronic obstructive pulmonary disease in GreeceKyriakos Souliotis, Hara Kousoulakou, Georgios Hillas, Nikolaos Tzanakis, Michalis Toumbis, Theodoros Vassilakopouloshttps://www.dovepress.com/getfile.php?fileID=36433, https://www.dovepress.com/getfile.php?fileID=36433
International Journal of Chronic Obstructive Pulmonary Disease10.2147/copd.s137712010341Direct costs of chronic obstructive pulmonary disease among managed care patientsAnand Dalalhttps://www.dovepress.com/getfile.php?fileID=7815
International Journal of Chronic Obstructive Pulmonary Disease10.2147/copd.s571572014289Indirect costs in chronic obstructive pulmonary disease: A review of the economic burden on employers and individuals in the United StatesJeetvan Patel, Anand Dalal, Saurabh Nagarhttps://www.dovepress.com/getfile.php?fileID=19343
Respiratory Medicine10.1053/rmed.1999.07202000943204-213Direct medical costs of chronic obstructive pulmonary disease: chronic bronchitis and emphysemaL WILSON, E.B DEVINE, K SOhttps://api.elsevier.com/content/article/PII:S0954611199907205?httpAccept=text/xml, https://api.elsevier.com/content/article/PII:S0954611199907205?httpAccept=text/plain
ClinicoEconomics and Outcomes Research10.2147/ceor.s804242015173The impact of chronic pain on direct medical utilization and costs in chronic obstructive pulmonary diseaseMelissa Roberts, Douglas Mapel, Heather Thomsonhttps://www.dovepress.com/getfile.php?fileID=24322
International Journal of Chronic Obstructive Pulmonary Disease10.2147/copd.s2309552020Volume 151529-1543

Efficacy and Safety of LAMA/LABA Fixed-Dose Combination Therapies in Chronic Obstructive Pulmonary Disease: A Systematic Review of Direct and Indirect Treatment Comparisons

John R Hurst, Kevin Gruffydd-Jones, Mousumi Biswas, Deniz Guranlioglu, Martin Jenkins, Neda Stjepanovic, Arushi Bamrarahttps://www.dovepress.com/getfile.php?fileID=59337, https://www.dovepress.com/getfile.php?fileID=59337
International Journal of Chronic Obstructive Pulmonary Disease10.2147/copd.s596732014813Once-daily long-acting beta-agonists for chronic obstructive pulmonary disease: an indirect comparison of olodaterol and indacaterolNeil Roskell, Antonio Anzueto, Alan Hamilton, Bernd Disse, Karin Beckerhttps://www.dovepress.com/getfile.php?fileID=21035
International Journal of Chronic Obstructive Pulmonary Disease10.2147/copd.s656932014569Outcomes and costs of treating chronic obstructive pulmonary disease with inhaled fixed combinations: the Italian perspective of the PATHOS studyAlessandro Roggeri, Claudio Micheletto, Daniela Paola Roggerihttps://www.dovepress.com/getfile.php?fileID=20335
Value in Health10.1016/j.jval.2014.08.20412014177A593-A594Economic Burden in Direct Costs of Chronic Obstructive Pulmonary Disease (COPD) in RussiaV. Krysanova, I. Krysanovhttps://api.elsevier.com/content/article/PII:S1098301514039710?httpAccept=text/xml, https://api.elsevier.com/content/article/PII:S1098301514039710?httpAccept=text/plain